Allient (ALNT) Competitors $23.36 -1.95 (-7.70%) Closing price 03/7/2025 04:00 PM EasternExtended Trading$23.36 +0.00 (+0.02%) As of 03/7/2025 05:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ALNT vs. TXG, TRNS, CTKB, SENS, EYPT, LAB, QTRX, AEHR, QSI, and NAUTShould you be buying Allient stock or one of its competitors? The main competitors of Allient include 10x Genomics (TXG), Transcat (TRNS), Cytek Biosciences (CTKB), Senseonics (SENS), EyePoint Pharmaceuticals (EYPT), Standard BioTools (LAB), Quanterix (QTRX), Aehr Test Systems (AEHR), Quantum-Si (QSI), and Nautilus Biotechnology (NAUT). These companies are all part of the "measuring and control equipment" industry. Allient vs. 10x Genomics Transcat Cytek Biosciences Senseonics EyePoint Pharmaceuticals Standard BioTools Quanterix Aehr Test Systems Quantum-Si Nautilus Biotechnology Allient (NASDAQ:ALNT) and 10x Genomics (NASDAQ:TXG) are both small-cap computer and technology companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, media sentiment, profitability, community ranking, dividends and analyst recommendations. Does the media prefer ALNT or TXG? In the previous week, Allient had 8 more articles in the media than 10x Genomics. MarketBeat recorded 20 mentions for Allient and 12 mentions for 10x Genomics. Allient's average media sentiment score of 0.61 beat 10x Genomics' score of 0.26 indicating that Allient is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Allient 3 Very Positive mention(s) 4 Positive mention(s) 11 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive 10x Genomics 1 Very Positive mention(s) 4 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral Do institutionals and insiders believe in ALNT or TXG? 61.6% of Allient shares are held by institutional investors. Comparatively, 84.7% of 10x Genomics shares are held by institutional investors. 15.6% of Allient shares are held by company insiders. Comparatively, 10.0% of 10x Genomics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Do analysts recommend ALNT or TXG? Allient currently has a consensus price target of $31.00, indicating a potential upside of 32.71%. 10x Genomics has a consensus price target of $20.21, indicating a potential upside of 72.77%. Given 10x Genomics' higher probable upside, analysts plainly believe 10x Genomics is more favorable than Allient.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Allient 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.2510x Genomics 1 Sell rating(s) 9 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.35 Is ALNT or TXG more profitable? Allient has a net margin of 2.64% compared to 10x Genomics' net margin of -29.90%. Allient's return on equity of 10.80% beat 10x Genomics' return on equity.Company Net Margins Return on Equity Return on Assets Allient2.64% 10.80% 4.75% 10x Genomics -29.90%-25.40%-19.69% Does the MarketBeat Community prefer ALNT or TXG? 10x Genomics received 55 more outperform votes than Allient when rated by MarketBeat users. However, 75.00% of users gave Allient an outperform vote while only 51.69% of users gave 10x Genomics an outperform vote. CompanyUnderperformOutperformAllientOutperform Votes675.00% Underperform Votes225.00% 10x GenomicsOutperform Votes6151.69% Underperform Votes5748.31% Which has more volatility & risk, ALNT or TXG? Allient has a beta of 1.59, meaning that its stock price is 59% more volatile than the S&P 500. Comparatively, 10x Genomics has a beta of 1.93, meaning that its stock price is 93% more volatile than the S&P 500. Which has better earnings & valuation, ALNT or TXG? Allient has higher earnings, but lower revenue than 10x Genomics. 10x Genomics is trading at a lower price-to-earnings ratio than Allient, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAllient$529.97M0.74$24.10M$0.8029.2010x Genomics$610.79M2.34-$182.63M-$1.52-7.70 SummaryAllient beats 10x Genomics on 12 of the 19 factors compared between the two stocks. Remove Ads Get Allient News Delivered to You Automatically Sign up to receive the latest news and ratings for ALNT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ALNT vs. The Competition Export to ExcelMetricAllientInstruments to measure electricity IndustryComputer SectorNASDAQ ExchangeMarket Cap$393.50M$4.50B$24.43B$8.33BDividend Yield0.51%0.47%2.79%4.02%P/E Ratio26.5521.5043.0619.35Price / Sales0.742.562,586.28118.07Price / Cash6.8617.8734.7334.62Price / Book1.513.276.254.23Net Income$24.10M$135.28M$737.78M$247.13M7 Day Performance-6.11%-5.34%-1.38%-2.38%1 Month Performance-3.51%-7.76%-4.92%-6.15%1 Year Performance-29.43%-13.01%8.36%2.83% Allient Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ALNTAllient4.2047 of 5 stars$23.36-7.7%$31.00+32.7%-29.4%$393.50M$529.97M26.551,950Earnings ReportDividend AnnouncementAnalyst RevisionTXG10x Genomics4.5783 of 5 stars$9.85-7.9%$20.57+108.8%-70.6%$1.20B$610.79M-6.481,240Analyst ForecastTRNSTranscat3.1443 of 5 stars$75.29-5.3%$111.50+48.1%-30.4%$700.88M$272.20M40.701,104News CoverageCTKBCytek Biosciences1.2403 of 5 stars$4.30-4.2%$6.88+59.9%-36.4%$553.89M$200.45M-53.74500SENSSenseonics1.8487 of 5 stars$0.87+2.4%$2.00+129.9%+3.4%$517.93M$22.21M-6.6990Earnings ReportEYPTEyePoint Pharmaceuticals1.2894 of 5 stars$5.72-8.8%$26.63+365.5%-70.8%$390.40M$45.71M-2.86120Earnings ReportAnalyst RevisionLABStandard BioTools3.3055 of 5 stars$1.01-5.2%$2.88+184.7%-58.3%$375.98M$174.43M-1.42620Positive NewsQTRXQuanterix1.6535 of 5 stars$7.09-6.6%$23.25+227.9%-72.1%$273.14M$132.53M-6.69460AEHRAehr Test Systems2.626 of 5 stars$8.85-8.2%$25.00+182.5%-45.5%$262.95M$50.74M11.8090QSIQuantum-Si2.3068 of 5 stars$1.30-5.8%$3.42+162.8%-42.2%$185.53M$2.27M-2.03150NAUTNautilus Biotechnology2.5124 of 5 stars$1.24-4.6%$3.58+189.0%-59.7%$155.70MN/A-2.21130 Remove Ads Related Companies and Tools Related Companies 10x Genomics Alternatives Transcat Alternatives Cytek Biosciences Alternatives Senseonics Alternatives EyePoint Pharmaceuticals Alternatives Standard BioTools Alternatives Quanterix Alternatives Aehr Test Systems Alternatives Quantum-Si Alternatives Nautilus Biotechnology Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ALNT) was last updated on 3/10/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAI Shock Coming on March 18? Prepare NowIf you’re worried about all the recent volatility in the market… Or if you have any money in AI stocks… ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Allient Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Allient With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ALNT Stock Alerts